A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Key Account Manager

Account ManagementConfirmed live in the last 24 hours
Full-timeGermanyNo salary listedIn-person

About the Job

Requirements

  • A university degree in a business-related field such as health or business management, or a comparable educational background.
  • Certification to promote medicinal products to the national code-of-practice standard in Germany.
  • At least 7 years of sales and key account management experience in bio/pharmaceutical sales.
  • Ability to gain consistent access to healthcare providers in reference centers and the community, and to develop strong professional relationships with them for product promotion.
  • Fluent German and English, both written and verbal.
  • Ability to travel regularly within an assigned territory, approximately 80% of the time.

Responsibilities

  • Strategically drive the commercial objectives of selected genetic programs in Germany within the assigned territory.
  • Develop, own, and implement territory-specific strategic account plans in alignment with overall product strategy and relevant internal functions, while complying with company, industry, legal, regulatory, and ethical standards.
  • Present a positive company image and build awareness of the RNAi platform among relevant healthcare professionals.
  • Develop territory and account plans, including customer targeting and cycle plans, aligned with Marketing strategy and Business Operations guidance.
  • Achieve pre-launch and post-launch key performance indicators, including sales and volume targets.
  • Use advanced sales skills to deliver consistent and continuous messaging.
  • Analyze the assigned territory to identify, assess, and develop relevant centers for diagnosis and treatment.
  • Drive patient-group identification, diagnosis, and referral rates through strategic intersectoral referral-network management with other field-based functions.
  • Develop trusted relationships with a portfolio of customers and understand their needs to support market penetration.
  • Coordinate with internal stakeholders and external centers to ensure products and services are delivered to customers on time.
  • Establish and maintain contact with key customers, provide commercial and scientific services, support access at the site of care, and ensure logistics are in place to administer products.
  • Plan and execute local meetings with Medical Affairs to support diagnosis and treatment rates among physicians and other healthcare professionals.
  • Represent the company at local and national events and congresses.
  • Serve as the communication link between key customers and internal teams.
  • Collaborate with Medical Affairs, Sales leadership, Marketing, Market Access, and Business Operations as needed.
  • Lead regular local alignment meetings with other field-based functions to support implementation and outcomes against territory and account plans.
  • Submit timely, accurate reports and maintain the customer relationship management database.
  • Conduct activities in accordance with applicable country codes of practice, laws, regulations, and ethical standards.
  • Travel domestically and occasionally internationally as needed.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs